RSV vaccine (adult)

🧮 Dose calculator

Immunisation (vaccination) · Regimen source: FDA Arexvy · 2.1FDA Arexvy · 1

• • Not for use in pregnancy. Likely unsafe under 2 y (enhanced respiratory disease in animal models). FDA Arexvy · 1FDA Arexvy · 8.4

Enter age (weight is optional for this regimen).

👥 Special populations

• 🤰 PregnancyUse with caution

  Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Arexvy · 8.1

  “Risk Summary All pregnancies have a risk of birth defect, loss, or other adverse outcomes.”

• 🤱 BreastfeedingUse with caution

  Label: use with caution while breastfeeding; see the label text. FDA Arexvy · 8.2

  “No human or animal data are available to assess the effects of AREXVY on the breastfed infant or on milk production/excretion.”

• 👶 ChildrenUse with caution

  The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Arexvy · 8.4

  “Evidence from an animal model strongly suggests that AREXVY would be unsafe in individuals younger than 2 years of age because of an increased risk of enhanced respiratory disease.”

• 👴 Older adultsUse with caution

  Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Arexvy · 8.5

  “Of the total number of participants (N = 24,966) who received AREXVY or placebo in study 1, 13,943 (55.8%) were 60 to 69 years of age, 8,978 (36.0%) were 70 to 79 years of age, and 2,045 (8.2%) were 80 years of age and older [see Adverse Reactions ( 6.1 ), Use in Specific Populations ( 8.6 ), and Clinical Studies ( …”

• ⚥ Females & males of reproductive potentialNo data

  The source for this drug has no section for this group.